Log in
Enquire now
‌

US Patent 10421807 Interleukin-31 monoclonal antibody

Patent 10421807 was granted and assigned to Zoetis on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Zoetis
Zoetis
Date Filed
December 5, 2018
Date of Patent
September 24, 2019
Patent Applicant
Zoetis
Zoetis
Patent Application Number
16210228
Patent Citations Received
‌
US Patent 12133867 Universal anti-CD22 chimeric antigen receptor engineered immune cells
0
‌
US Patent 11505611 FGFR3 antibodies and methods of use
‌
US Patent 12129297 Antibodies against TIM3 and uses thereof
0
‌
US Patent 12129300 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11485787 Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof
‌
US Patent 11525005 Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof
‌
US Patent 11535675 Antigen-binding proteins that antagonize leptin receptor
‌
US Patent 11566066 Anti-GDF15 antibodies, compositions and methods of use
‌
US Patent 11572409 Antibodies having specificity for BTN2 and uses thereof
‌
US Patent 11591392 Antibodies against TIM3 and uses thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10421807
Patent Primary Examiner
‌
Elizabeth C. Kemmerer

Find more entities like US Patent 10421807 Interleukin-31 monoclonal antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.